Fredericks S - Search Results

1

Prasad K, Fredericks S, Holt DW. Prasad K, et al. Among authors: fredericks s. Lancet. 1996 Aug 31;348(9027):626. doi: 10.1016/S0140-6736(05)64852-0. Lancet. 1996. PMID: 8774612 No abstract available.

2

Serum neopterin in acute coronary syndromes.

Gupta S, Fredericks S, Schwartzman RA, Holt DW, Kaski JC. Gupta S, et al. Among authors: fredericks s. Lancet. 1997 Apr 26;349(9060):1252-3. doi: 10.1016/s0140-6736(05)62447-6. Lancet. 1997. PMID: 9130969 No abstract available.

3

Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance.

Sadiq ST, Fredericks S, Khoo SH, Rice P, Holt DW. Sadiq ST, et al. Among authors: fredericks s. AIDS. 2005 Oct 14;19(15):1716-7. doi: 10.1097/01.aids.0000186828.99032.60. AIDS. 2005. PMID: 16184054 No abstract available.

4

TGF-beta quantitation can be tricky.

Fredericks S, Holt DW. Fredericks S, et al. Transplantation. 1999 Aug 27;68(4):468-9. doi: 10.1097/00007890-199908270-00002. Transplantation. 1999. PMID: 10480399 No abstract available.

5

Response to "Increased creatine kinase MB and cardiac troponin T with normal cardiac troponin I in metastatic alveolar rhabdomyosarcoma".

Fredericks S, Collinson PO, Holt DW. Fredericks S, et al. Clin Chem. 2000 Mar;46(3):432-5. Clin Chem. 2000. PMID: 10702539 No abstract available.

6

Release of platelet activation markers during coronary angioplasty.

Korovesis S, Fredericks S, Holt D, Toutouzas P, Kaski JC, Webb-Peploe MM, Katritsis D. Korovesis S, et al. Among authors: fredericks s. Coron Artery Dis. 2000 Jul;11(5):391-8. doi: 10.1097/00019501-200007000-00003. Coron Artery Dis. 2000. PMID: 10895405

7

Pharmacogenomics of immunosuppressive drug metabolism.

Fredericks S, Holt DW. Fredericks S, et al. Curr Opin Nephrol Hypertens. 2003 Nov;12(6):607-13. doi: 10.1097/00041552-200311000-00006. Curr Opin Nephrol Hypertens. 2003. PMID: 14564197 Review.

8

Comment on: HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 2005; 33(11):1309-1319.

Fredericks S, Holt DW. Fredericks S, et al. Exp Hematol. 2006 May;34(5):575-6; author reply 577-8. doi: 10.1016/j.exphem.2006.02.006. Exp Hematol. 2006. PMID: 16647561 Free article. No abstract available.

9

Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?

Tziakas DN, Kaski JC, Chalikias GK, Romero C, Fredericks S, Tentes IK, Kortsaris AX, Hatseras DI, Holt DW. Tziakas DN, et al. Among authors: fredericks s. J Am Coll Cardiol. 2007 May 29;49(21):2081-9. doi: 10.1016/j.jacc.2006.08.069. Epub 2007 May 17. J Am Coll Cardiol. 2007. PMID: 17531656 Free article.

10

Markers of myocardial damage.

Fredericks S, Merton G, Lerena MJ, Holt DW. Fredericks S, et al. Clin Chem. 1998 Feb;44(2):362-5. Clin Chem. 1998. PMID: 9474046 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page